Suppliers / Zhejiang East-Asia Pharmaceutical

Zhejiang East-Asia Pharmaceutical

China Updated 9 July 2026

Zhejiang East-Asia Pharmaceutical is an API manufacturer based in China. It holds 3 valid CEPs across a filed portfolio of 3 molecules. Its filings concentrate with MINSA (CR), NAFDAC (NG) and UZPHARM (UZ). Its GMP standing is certified by MFDS (Korea).

0
active US DMFs
3
valid CEPs
3
registered plants
11
filings across 3 regulators

Registered plants

Site FDA FEI
Taizhou, China Not on file
Taizhou, China Not on file
Pubagang, China Not on file

What they file, and where

Molecule Regulators Docs
Levofloxacin EDQM 1
Terbinafine EDQM 1
Trimebutine EDQM 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 7 None
NAFDAC (NG) 3 None
UZPHARM (UZ) 1 None
MFDS (Korea) None 4

Comparing suppliers?

Choose your molecules and target markets. Zhejiang East-Asia Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates